[HTML][HTML] Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology

MM Rahman, S Bibi, MS Rahaman, F Rahman… - Biomedicine & …, 2022 - Elsevier
Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC–MS/LC–MS characterization …

SK Das, S Mahanta, B Tanti, H Tag, PK Hui - Molecular Diversity, 2022 - Springer
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) is a massive viral disease outbreak of international concerns. The present …

Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors

SS Elhady, RFA Abdelhameed, RT Malatani… - Biology, 2021 - mdpi.com
Simple Summary The ongoing coronavirus disease-2019 (COVID-19) pandemic shows
unprecedented challenges for the worldwide healthcare system. Despite the large clinical …

In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19

S Mujwar, RK Harwansh - Structural Chemistry, 2022 - Springer
COVID-19 was caused by a novel coronavirus known as SARS-CoV-2. The COVID-19
disease outbreak has been avowed as a global pandemic by the World Health Organization …

[HTML][HTML] An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2

F Yan, F Gao - Computational and structural biotechnology journal, 2021 - Elsevier
There is an urgent need to develop effective treatments for coronavirus disease 2019
(COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS …

Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves

R Ghosh, A Chakraborty, A Biswas… - Journal of Biomolecular …, 2022 - Taylor & Francis
SARS CoV-2 is the causative agent of the pandemic disease COVID-19. There is an urgent
need for effective drugs or vaccines which can effectively combat this outbreak. The main …

Cheminformatics-based identification of potential novel anti-SARS-CoV-2 natural compounds of African origin

SK Kwofie, E Broni, SO Asiedu, GB Kwarko, B Dankwa… - Molecules, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome virus 2 (SARS-CoV-2) has impacted negatively on public health and …

In silico identification of new anti-SARS-CoV-2 agents from bioactive phytocompounds targeting the viral spike glycoprotein and human TLR4

NC Das, RK Labala, R Patra… - Letters in Drug …, 2022 - ingentaconnect.com
Background: The recent outbreak of novel coronavirus disease (COVID-19) pandemic
caused by SARS-CoV-2 has posed a tremendous threat to mankind. The unavailability of a …

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation

AK Bepari, HM Reza - PeerJ, 2021 - peerj.com
Background The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has ravaged lives
across the globe since December 2019, and new cases are still on the rise. Peoples' …